STOCK TITAN

Notifications

Limited Time Offer! Get Platinum at the Gold price until January 31, 2026!

Sign up now and unlock all premium features at an incredible discount.

Read more on the Pricing page

[144] Nuvation Bio Inc. SEC Filing

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
144

Rhea-AI Filing Summary

NUVB filed a notice that an affiliated holder, named in the form, plans to sell 10,000 shares of Class A common stock through Morgan Stanley Smith Barney on the NYSE, with an aggregate market value of $75,000.00. The filing states that these shares were acquired on 11/25/2025 by exercising options under a registered plan, paid in cash.

The notice also lists recent sales for the same seller over the past three months, including 20,000 common shares sold on 11/20/2025 for gross proceeds of $140,074.00, 15,000 Class A common shares sold on 11/19/2025 for $76,552.50, and 15,000 Class A common shares sold on 11/17/2025 for $71,475.00. Shares of Class A common stock outstanding were reported as 342,833,433.

Positive

  • None.

Negative

  • None.

144: Filer Information

144: Issuer Information

144: Securities Information



Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold


* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.



Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

144: Remarks and Signature

FAQ

What does NUVB’s latest Form 144 filing disclose?

The Form 144 discloses that a holder of NUVB securities intends to sell 10,000 shares of Class A common stock on the NYSE with an aggregate market value of $75,000.00.

How were the NUVB shares in the planned Form 144 sale acquired?

The 10,000 Class A common shares were acquired on 11/25/2025 through the exercise of options under a registered plan, with the purchase price paid in cash.

Which broker is handling the NUVB Form 144 sale and on which exchange?

The planned sale of NUVB Class A common shares is to be executed through Morgan Stanley Smith Barney LLC Executive Financial Services on the NYSE.

What recent NUVB stock sales by the same seller are reported in the Form 144?

The notice reports sales over the past three months: 20,000 common shares on 11/20/2025 for $140,074.00, 15,000 Class A common shares on 11/19/2025 for $76,552.50, and 15,000 Class A common shares on 11/17/2025 for $71,475.00.

How many NUVB Class A common shares are outstanding according to the Form 144?

The Form 144 states that 342,833,433 shares of NUVB Class A common stock were outstanding.

What representation does the seller make in NUVB’s Form 144 notice?

By signing the notice, the seller represents that they do not know any material adverse information about NUVB’s current or prospective operations that has not been publicly disclosed.
Nuvation Bio Inc

NYSE:NUVB

NUVB Rankings

NUVB Latest News

NUVB Latest SEC Filings

NUVB Stock Data

2.70B
274.71M
19.03%
66.74%
19.91%
Biotechnology
Pharmaceutical Preparations
Link
United States
SAN FRANCISCO